developmentstoday

Ask DT AI Audio Brief Videos Podcast +

Ask DT AI Audio Brief Videos Podcast

HomeHealth

Health

Health

Medical breakthroughs and health tech

Explore Related Topics

Science AI & Robotics Innovation Culture

Company

About Us
Advertise
Contact
Editorial Policy

Legal

Terms of Service
Privacy Policy
Cookie Policy
AI & Ethics Policy
Do Not Sell My Info
FAQ
Archive
Site Map

Discover

Newsletter
Ask DT AI
Audio Brief
Videos
Podcast
DT Premium

Connect

Twitter / X
Facebook
LinkedIn
YouTube
Instagram
TikTok
Flipboard
RSS Feed

© 2026 Developments Today. All rights reserved.

Updated: Novartis adds fuel to breast cancer drug race in $2B upfront buy of next-gen PI3Kα inhibitor

Novartis Pays $2B Upfront for Next-Gen Breast Cancer Drug

Novartis pays $2 billion upfront for Synnovation's more selective PI3K-alpha inhibitor for breast cancer
The deal targets the toxicity limitations of Novartis's existing drug alpelisib, which causes severe hyperglycemia
Greater isoform selectivity could expand treatment eligibility to patients currently excluded due to metabolic conditions

DE

DT Editorial Team·Mar 21, 2026·via endpoints.news

More in Health→

Pfizer seeks earlier use of Talzenna in prostate cancer with Phase 3 win

Pfizer's Talzenna Wins Phase 3 for Earlier Prostate Cancer Use

Pfizer's Talzenna plus Xtandi combination succeeded in Phase 3 metastatic prostate cancer trial
PARP inhibitors exploit DNA repair deficiencies in tumor cells to selectively kill cancer
Trial success in a broad patient population could expand access well beyond BRCA-mutated cases

DE

DT Editorial Team·Mar 20, 2026·2 min read·via endpoints.news

More in Health→

Washington’s Medicaid program will pay for ElliQ, an AI robot for loneliness

Washington Medicaid Will Pay for an AI Robot to Fight Senior Loneliness

Washington is the first state to cover an AI companion robot through Medicaid for elderly residents
ElliQ by Intuition Robotics engages seniors in conversation, medication reminders, and family video calls
The policy reflects growing recognition of social isolation as a quantifiable clinical risk factor

DE

DT Editorial Team·Mar 20, 2026·3 min read·via endpoints.news

More in Health→

The indirect — and sometimes surprising — benefits of vaccines

Vaccines Do More Than Advertised: The Hidden Benefits

BCG and measles vaccines reduce child mortality from unrelated diseases through non-specific immune training
Herd protection shields newborns and immunocompromised patients who cannot be vaccinated themselves
Flu vaccination reduces secondary bacterial infections, cutting antibiotic use and downstream resistance development

DE

DT Editorial Team·Mar 19, 2026·4 min read·via statnews.com

More in Health→

National survey of NIH-funded researchers shows precarious state of U.S. science — ‘This is like the Titanic’

NIH Funding Crisis: A Survey of American Science in Freefall

25% of NIH-funded researchers have laid off lab members; 40% have canceled planned research projects
67% are advising students to consider careers outside academic science, signaling deep pipeline damage
International competitors are actively recruiting US-trained researchers displaced by funding instability

DE

DT Editorial Team·Mar 19, 2026·4 min read·via statnews.com

More in Health→

More than 150,000 uncounted Covid-19 deaths occurred early in the pandemic, a study finds

Study: 150,000 COVID Deaths Went Uncounted in Pandemic's Early Years

AI-assisted research estimates 155,000 COVID deaths went uncounted outside hospitals in 2020 and 2021
The official toll of 840,000 may have been undercounted by roughly 16 percent
Rural areas and racial minority communities had the highest rates of unrecognized COVID mortality
The findings highlight gaps in US death reporting infrastructure that remain partially unresolved

DE

DT Editorial Team·Mar 19, 2026·4 min read·via statnews.com

More in Health→

FDA approves J&J

FDA Approves J&J's Icotyde, a New Psoriasis Pill With $5B+ Potential

FDA approved J&J's icotrokinra (Icotyde) for moderate-to-severe plaque psoriasis in patients aged 12 and older
Icotyde is an oral small molecule inhibitor, offering a pill alternative to existing injectable biologic treatments
J&J projects peak annual sales exceeding $5 billion, making it a potential megablockbuster
Psoriasis affects 125 million people worldwide and the oral format could reach patients who avoid injections

DE

DT Editorial Team·Mar 19, 2026·3 min read·via endpoints.news

More in Health→

Drugmakers consider licensing deal tweaks to soften MFN impact

Pharma Industry Reshapes Licensing Deals to Blunt MFN Drug Pricing

Pharma companies are restructuring international licensing agreements to reduce price transparency that MFN calculations would use
Lawyers confirm the strategies are legal adaptations to evolving MFN rules, not evasion schemes
Biologics face the biggest MFN exposure due to the largest US-to-global price gaps in that drug category

DE

DT Editorial Team·Mar 18, 2026·3 min read·via endpoints.news

More in Health→

CMS innovation center to expand staff with focus on drug pricing, director says

CMS Doubles Innovation Team to Drive Down Medicare Drug Costs

CMS Innovation Center is more than doubling its dedicated drug pricing team to run new pilot programs
Expansion targets Medicare and Medicaid prescription costs through multiple concurrent model tests
The move complements the Inflation Reduction Act's direct drug negotiation provisions already in effect for 2026

DE

DT Editorial Team·Mar 18, 2026·3 min read·via endpoints.news

More in Health→

Needle-Free Universal Vaccine Protects Against Multiple Pathogens

Needle-Free Universal Vaccine Protects Against Multiple Pathogens

Needle-free intranasal vaccine generated broad protection against diverse respiratory bacteria and viruses in mice
Mucosal delivery targets immune defenses directly at the respiratory entry point, potentially intercepting infection earlier
Breadth of protection attributed to combined innate immune priming and adaptive responses to specific antigens

DE

DT Editorial Team·Mar 18, 2026·2 min read·via nature.com

More in Health→

AI Co-Scientists Now Generating Validated Research Hypotheses

AI Co-Scientists Now Generating Validated Research Hypotheses

AI co-scientists now generate specific mechanistic hypotheses that research teams systematically validate in laboratory settings
Organoids serve as the key validation layer — human-relevant and scalable enough to test high volumes of AI hypotheses
Some AI-originated hypotheses have progressed to early-stage clinical trials, marking a new milestone for AI in science

DE

DT Editorial Team·Mar 18, 2026·3 min read·via nature.com

More in Health→

EPA Proposes Loosening Limits on Cancer-Linked Sterilization Gas

The EPA proposes loosening emission limits for ethylene oxide, a known carcinogen used to sterilize about 50% of US medical devices
EtO is linked to elevated lymphoma and breast cancer rates in workers and communities near sterilization facilities
The agency cites medical supply chain concerns, but critics say the rollback accepts preventable cancer risk

DE

DT Editorial Team·Mar 17, 2026·3 min read·via medicalxpress.com

More in Health→

AI Smoking Cessation Tool Boosts Quit Rates at Scale

CHOP's automated smoking cessation system produced a 3.9% absolute increase in maternal quit rates
The system integrates with electronic health records to automatically identify and contact tobacco users
Researchers project the approach could protect hundreds of thousands of children from secondhand smoke annually

DE

DT Editorial Team·Mar 17, 2026·4 min read·via medicalxpress.com

More in Health→

Clinical development of cancer vaccines - Nature Medicine

Cancer Vaccines Enter a New Clinical Era

Personalized mRNA cancer vaccines use tumor sequencing to target neoantigens unique to each patient's cancer
Moderna/Merck mRNA-4157 showed significant melanoma recurrence reduction in Phase 2, driving broader clinical expansion
Combination approaches pairing vaccines with checkpoint inhibitors are advancing across multiple tumor types
Multiple Phase 3 trials now underway will determine if cancer vaccines become standard-of-care treatment

DE

DT Editorial Team·Mar 16, 2026·5 min read·via nature.com

More in Health→

Structure Therapeutics reports more Phase 2 data for oral GLP-1

Oral GLP-1 Drug Shows Promise in New Phase 2 Trial Data

Structure Therapeutics reports Phase 2 data showing GSBR-1290 produces meaningful weight reduction in obesity patients
Small-molecule design approach aims to improve oral bioavailability over peptide-based GLP-1 drugs
GI side effects appeared at manageable rates, addressing a key tolerability challenge for the drug class
An effective oral GLP-1 would expand access to millions who cannot or prefer not to use injectables

DE

DT Editorial Team·Mar 16, 2026·5 min read·via endpoints.news

More in Health→

Physical activity for public health in the 21st century - Nature Medicine

Physical Activity Must Become a Pillar of 21st-Century Public Health

Global physical inactivity rates are stagnant despite extensive evidence of health benefits
Structural factors like car-centric cities drive inactivity more than individual choices
Health systems need to integrate exercise referral pathways as standard clinical practice

DE

DT Editorial Team·Mar 16, 2026·4 min read·via nature.com

More in Health→

Modifiable risk factors drive a large share of the global cancer burden - Nature Medicine

Lifestyle Factors Drive Nearly Half of Global Cancer Cases

Modifiable factors like tobacco, obesity, and alcohol drive a large share of global cancer cases
Growing obesity rates are increasing cancer burden as smoking rates decline
Prevention interventions could save hundreds of thousands of lives annually

DE

DT Editorial Team·Mar 16, 2026·4 min read·via nature.com

More in Health→

Telehealth Keeps Breast Cancer Patients on Track with Treatment

Monthly telehealth nurse check-ins raise breast cancer medication adherence from 61% to 78% after one year
Primary mechanism: early identification of side effects before they cause patients to quit treatment
Findings support permanent telehealth coverage expansion for oncology, especially in rural and underserved areas

DE

DT Editorial Team·Mar 15, 2026·3 min read·via statnews.com

More in Health→

Sweet Cherry Compounds Show Promise in Slowing Aggressive Breast Cancer Spread, Texas A&M Study Discovers (via vetmed.tamu.edu)

Cherry Compounds Show Promise Against Aggressive Breast Cancer

Mouse study finds dark sweet cherry extracts slow triple-negative breast cancer growth via anthocyanin compounds
Compounds appeared to inhibit tumor signaling, reduce angiogenesis, and trigger cancer cell death in animal models
Effective concentrations far exceed what whole fruit consumption could achieve — human trials are years away

DE

DT Editorial Team·Mar 15, 2026·3 min read·via sciencedaily.com

More in Health→

Psychedelics Make the Brain Hallucinate Its Own Memories

Psychedelics appear to make the brain weight stored memories over real-time sensory input
Mouse study shows shift toward top-down memory-based visual processing under psychedelic compounds
Mechanism may explain why hallucinations feel personally meaningful and has implications for therapeutic protocols

DE

DT Editorial Team·Mar 15, 2026·2 min read·via medicalxpress.com

More in Health→

……